Overview

The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers

Status:
Completed
Trial end date:
2021-03-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HIP2001 and HGP2001 in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited